Ann Hematol (2017) 96:1587–1588 DOI 10.1007/s00277-017-3052-4 LETTER TO THE EDITOR Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients 1,2 2 2 Hiroshi Ureshino & Kazuharu Kamachi & Masaharu Miyahara Received: 23 May 2017 /Accepted: 15 June 2017 /Published online: 27 June 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, genase and soluble interleukin-2 receptor did not decrease, Human T-cell lymphotropic virus type I (HTLV-I) specific indicating that ATL was refractory. Subsequently, cytotoxic T lymphocytes (CTLs) exhibit cytotoxicity against mogamulizumab and half-doses of cyclophosphamide, doxo- HTLV-I infected T-cells, resulting in the regulation of HTLV-I rubicin, vincristine, and prednisolone (CHOP) were adminis- tered. After two courses of chemotherapy, the patient achieved proviral load. CTLs are rarely seen in adult T-cell leukemia/ lymphoma (ATL) patients, but are strongly activated in some and remained in CR >42 months. HTLV-I specific CTLs were ATL patients who remain in complete remission (CR) after detected (0.38%) in her PB at 14 months after allogenic stem cell transplantation (allo-SCT) ; moreover, mogamulizumab administration (Fig. 1). CTLs also regulate ATL disease progression . Tax peptide- Our patient achieved extremely long-term remission after pulsed dendritic cell vaccination can strongly
Annals of Hematology – Springer Journals
Published: Jun 27, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera